| Financial Year |
March 31 2023 |
| Monetary Funds |
8,964,895,091.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
6,275,960,376.02 |
| Advances to Suppliers |
31,480,715.48 |
| Other Receivables |
89,241,887.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,109,305,992.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
167,347,848.23 |
| Other Current Assets |
1,222,486,437.51 |
| Total Current Assets |
21,175,743,544.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
45,444,377.48 |
| Long-term Equity Investment |
4,151,113,916.88 |
| Investment Properties |
142,299,995.30 |
| Fixed Assetes |
22,320,542,474.82 |
| Under-construction Projects |
27,657,820,987.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,386,399,773.75 |
| R&D expenses |
365,231,148.33 |
| Goodwill |
268,423,090.92 |
| Long-Term Deferred and Prepaid Expenses |
867,490,708.39 |
| Deferred Income Tax Assets |
1,210,122,420.51 |
| Other Non-Current Assets |
10,024,225.76 |
| Sub-Total of Non-Current Assets |
59,524,484,381.03 |
| Total Assets |
80,700,227,925.82 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,904,759,416.38 |
| Accounts Payable |
5,673,230,879.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
592,114,786.12 |
| Taxes Payable |
148,265,821.25 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,201,921,173.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,833,067,591.49 |
| Other Current Liabilities |
204,337,731.90 |
| Sub-Total of Current Liabilities |
18,917,636,158.20 |
| Long-term Loans |
21,896,383,138.37 |
| Bonds Payable |
7,995,260,363.88 |
| Long-Term Accounts Payable |
210,989,109.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,047,072.16 |
| Deferred Income Tax Liabilities |
38,747,425.87 |
| Other Non-Current Liabilities |
1,000,000,000.00 |
| Sub-Total of Non-Current Liabilities |
32,065,972,916.26 |
| Total Liabilities |
50,983,609,074.46 |
| Paid-In Capital(Or Share Stock) |
2,457,747,661.00 |
| Capital Surplus |
26,235,208,505.79 |
| Surplus Reserve |
235,086,089.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
576,869,077.59 |
| Minority Stockholder's Interest |
342,277,553.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,374,341,297.97 |
| Owner's Equity（Stockholder's Equity） |
29,716,618,851.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
80,700,227,925.82 |
